Skip to contentB
Biofrontera Inc.
B
BFRIBiofrontera Inc. Q1 2025 · 10-Q
Revenue$8.59M$8.59M+8.5% vs Q1 2024 Net Income-$4.20M-$4.20MN/M vs Q1 2024 EPS Diluted-$0.47-$0.47N/M vs Q1 2024 Operating Income-$4,547,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biofrontera Inc. · CIK 1858685 · Engraved from SEC EDGAR
Free Cash Flowderived-$4,120,000N/M Margins · derivedOperating margin-52.9%+16.2 pt vs Q1 2024
Net margin-48.9%+83.0 pt vs Q1 2024
ended Mar 31, 2025 · filed May 15, 2025 · 45 d after period end